MONTREAL, Nov. 13, 2025 /CNW/ - Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendations for the reimbursement of Blenrep (R) (belantamab mafodotin) -- a critical new ...

Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendations for the reimbursement of Blenrep® ...

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and ...

Marc S. Raab, MD, PhD, discusses the different ways that combination therapy that includes teclistamab can benefit patients with multiple myeloma.

NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...

GSK has received approval from the US Food and Drug Administration (FDA) for Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of multiple ...

Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 9:30 AM ESTCompany ParticipantsAaron ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The DREAMM-7 trial showed tolerability and safety profiles consistent with those observed for individual therapies. Credit: ...

Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product ...

Whether you’re into adventure sports or just want to log your day-to-day activities, an action camera is the way to go. On top of regular models from the likes of GoPro, DJI and Insta360, you can film ...